Compare Rans Entertainmen Indonesia Tbk (RANS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rans Entertainmen Indonesia Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Rans Entertainmen Indonesia Tbk trades at Rp200 (market cap 2.57T, 67.92M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Rans Entertainmen Indonesia Tbk is far larger — about 24.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| RANS | SCPI | |
|---|---|---|
Market Cap | 2.57T | 104.4B |
Volume | 67.92M | — |
Lot | 679.19K | — |
Turnover | 13.51B | — |
Average Price | 198.89 | — |
Value | 13.51B | — |
Indicative Equilibrium Price | 200 | — |
Indicative Equilibrium Volume | 4.66K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rans Entertainmen Indonesia Tbk
PT. Rans Entertainmen Indonesia Tbk. (the Company) was established with Deed No. 04 on October 18, 2016, which was made before Raden Mas Dendy Subangil S.H., M.Kn., under the name of PT RNR Film Internasional. The Company started its commercial operations in 2018. The Company does not have a parent entity, the ultimate controlling party is Raffi Farid Ahmad as the Companys shareholder.
Read more on RANS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
